Abstract
Abstract only
- Title
- QUADRA: A phase 2, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) who have received ≥3 prior chemotherapy regimens
- Creators
- Kathleen N. Moore - University of Oklahoma Health Sciences CenterAngeles Alvarez Secord - Duke Medical CenterMelissa Ann Geller - University of Minnesota Medical CenterDavid S. Miller - Southwestern Medical CenterNoelle Gillette Cloven - Texas OncologyGini F. Fleming - University of ChicagoAndrea Elisabeth Wahner Hendrickson - Mayo Clinic, Rochester, MNMasoud Azodi - Smilow Cancer HospitalPaul DiSilvestro - Women & Infants Hospital of Rhode IslandAmit M. Oza - Princess Margaret Cancer CentreMihaela C. Cristea - City Of Hope National Medical CenterJonathan S. Berek - Stanford Women’s Cancer Center, Stanford, CA;John K. Chan - Sutter HealthYong Li - TesaroRomnee Clark - TesaroUrsula A. Matulonis - Harvard UniversityBradley J. Monk - The US Oncology Network
- Publication Details
- Journal of clinical oncology, Vol.36(15_suppl), pp.5514-5514
- Identifiers
- 991005969149402656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article